Amphastar Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of AMPH for the last quarter is 178.10 M USD, and it's 1.36% lower compared to the previous quarter. The net income of Q4 23 is 36.17 M USD.